Introduction and objectives: Rosacea is a chronic inflammatory skin disease that affects quality of life and involves a variable clinical spectrum. Its prevalence oscillates between 2-10% and affects predominantly women in their 30s. Given its chronicity, it represents a high outlay for patients, who must invest in expensive topical and systemic treatments that Colombia’s health system does not cover. Our objective was to estimate the costs of rosacea’s treatment per month and in the third month of treatment in a dermatology center in Bogotá, Colombia.